Detail Information of Disease-specific Protein Abundances
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0518 Transporter Info | ||||
Gene Name | CACNA1A | ||||
Protien Name | Voltage-gated calcium channel alpha Cav2.1 | ||||
Gene ID | |||||
UniProt ID |
Disease-specific Protein Abundances of DT (DPAD) | |||||
---|---|---|---|---|---|
ICD-11: 01 Certain infectious or parasitic disease | |||||
[+] ICD-11: 1E50.1 Acute hepatitis B (viral hepatitis B) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Liver | ||||
The Specified Disease | Hepatitis b virus infection [ICD-11:1E50.1] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0024533419618209; Fold-change:0.9436226474119184; Z-score:-3.278710613 | ||||
![]() |
Please Click the above Thumbnail to View/Download the Expression Barchart for All Samples | ||||
[+] ICD-11: 1G50.0 Plasmodium falciparum malaria | Click to Show/Hide the Full List | ||||
The Studied Tissue | Blood | ||||
The Specified Disease | Plasmodium falciparum malaria [ICD-11:1G50.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.788962945983571; Fold-change:0.9991122236352936; Z-score:-0.074225064 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 02 Neoplasm | |||||
[+] ICD-11: 2A00.0Y Ependymoma (other specified primary brain neoplasm) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brain | ||||
The Specified Disease | Ependymoma [ICD-11:2A00.0Y] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:2.7479558194062075e-06; Fold-change:0.8317485803019155; Z-score:-2.409682701 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2A00.10 Medulloblastoma | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brain | ||||
The Specified Disease | Medulloblastoma [ICD-11:2A00.10] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0010820371249833; Fold-change:0.8447044761903343; Z-score:-3.419184552 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2A00.1Y Glioblastoma (other specified malignant neoplasm of brain) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brain | ||||
The Specified Disease | Glioblastoma [ICD-11:2A00.1Y] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:8.609446137982771e-05; Fold-change:0.7739162212220958; Z-score:-5.037808673 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2A00.1Y Large-cell medulloblastoma | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brain | ||||
The Specified Disease | Medulloblastoma, large cell [ICD-11:2A00.10] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0064026830672006; Fold-change:0.7343642620203088; Z-score:-4.678269826 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2A00.1Y Primitive neuroectodermal tumor (PNET) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brain | ||||
The Specified Disease | Primitive neuroectodermal tumor [ICD-11:2A00.Y] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:1.7412547672287982e-05; Fold-change:0.7216602354507706; Z-score:-5.491751372 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2A82.0 Chronic lymphocytic leukaemia of B-cell type | Click to Show/Hide the Full List | ||||
The Studied Tissue | Blood | ||||
The Specified Disease | Cll [ICD-11:2A82.00] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0003274200917256; Fold-change:1.1130340178581457; Z-score:2.143176073470188 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2B91 Colorectal adenocarcinoma | Click to Show/Hide the Full List | ||||
The Studied Tissue | Colon | ||||
The Specified Disease | Colorectal adenocarcinoma [ICD-11:2B91] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.1669713049059564; Fold-change:0.9873592167924988; Z-score:-0.388339427 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2B91 Colorectal carcinoma (colorectal cancer) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Blood | ||||
The Specified Disease | Colorectal cancer [ICD-11:2B91] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.1353854935486482; Fold-change:1.0176316184931422; Z-score:0.474568393057742 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Colon | ||||
The Specified Disease | Colorectal cancer [ICD-11:2B91] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0022124956462705; Fold-change:6.75; Z-score:3.387705967780842 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C10 Malignant neoplasm of pancreas (ductal adenocarcinoma) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Liver | ||||
The Specified Disease | Primary pancreatic ductal adenocarcinoma [ICD-11:2C10] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.661536805039294; Fold-change:1.0046235374913577; Z-score:0.3397951977102272 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Pancreas | ||||
The Specified Disease | Primary pancreatic ductal adenocarcinoma [ICD-11:2C10] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.1220031508141145; Fold-change:0.8659081950062857; Z-score:-1.204955854 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C25 Malignant neoplasms of bronchus or lung | Click to Show/Hide the Full List | ||||
The Studied Tissue | Saliva | ||||
The Specified Disease | Lung cancer [ICD-11:2C25] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.7905467209664971; Fold-change:0.9818951481732868; Z-score:-0.140129416 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C25.0 Adenocarcinoma of bronchus or lung | Click to Show/Hide the Full List | ||||
The Studied Tissue | Blood | ||||
The Specified Disease | Lung adenocarcinoma [ICD-11:2C25] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.4459054664014966; Fold-change:0.9933116043018432; Z-score:-0.115302857 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Lung | ||||
The Specified Disease | Lung adenocarcinoma [ICD-11:2C25] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.000527353403848; Fold-change:1.035955576491124; Z-score:1.3858271803053006 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Lung | ||||
The Specified Disease | Lung adenocarcinomas [ICD-11:2C25] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0184326475840349; Fold-change:0.9656435846519572; Z-score:-0.957208868 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C25.0Z Non-small cell carcinoma of lung, unspecified | Click to Show/Hide the Full List | ||||
The Studied Tissue | Lung | ||||
The Specified Disease | Non small cell lung cancer [ICD-11:2C25] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.9730351580110632; Fold-change:1.0029438941327058; Z-score:-0.006198993 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C25.1 Small cell carcinoma of bronchus or lung | Click to Show/Hide the Full List | ||||
The Studied Tissue | Lung | ||||
The Specified Disease | Small cell lung carcinoma [ICD-11:2C25] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0239964130311622; Fold-change:8.113924050632912; Z-score:3.0175931772617184 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C31 Squamous cell carcinoma of skin | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skin | ||||
The Specified Disease | Squamous cell carcinoma [ICD-11:2C31.Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0124966706253975; Fold-change:3; Z-score:6.127258315155433 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C90 Malignant neoplasm of kidney, except renal pelvis (clear cell type) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Kidney | ||||
The Specified Disease | Clear cell renal carcinomas [ICD-11:2C90] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:2.1229879370885573e-06; Fold-change:0.92193497172953; Z-score:-2.979714825 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C90.0 Renal cell carcinoma of kidney, except renal pelvis (chromophobe type) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Kidney | ||||
The Specified Disease | Chromophobe renal cell carcinoma [ICD-11:2C90.Y] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.9696623376880816; Fold-change:1.008513685339162; Z-score:-0.021512277 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C90.0 Renal cell carcinoma of kidney, except renal pelvis (papillary type) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Kidney | ||||
The Specified Disease | Papillary renal cell carcinoma [ICD-11:2C90.Y] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.9347641803629774; Fold-change:1.0178564038646574; Z-score:-0.070582239 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C90.Y Nephroblastoma (Wilms tumor) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Kidney | ||||
The Specified Disease | Nephroblastoma [ICD-11:2C90.Y] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.2491435155747164; Fold-change:0.9583852284657716; Z-score:-1.120571954 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2C94.2 Urothelial carcinoma of bladder | Click to Show/Hide the Full List | ||||
The Studied Tissue | Bladder | ||||
The Specified Disease | Urothelial carcinoma [ICD-11:2C94.2] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.4800713775959193; Fold-change:1.0406528429991666; Z-score:0.3940086580925722 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2E86.0 Leiomyoma of uterus (uterine fibroid) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Uterus | ||||
The Specified Disease | Uterine fibroid [ICD-11:2E86.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.911603393300494; Fold-change:1.0003331551458747; Z-score:0.0716608538205087 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2F32.0 Adenoma of colon (benign colon polyp) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Colon | ||||
The Specified Disease | Colon adenoma [ICD-11:2F32.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.281615454617181; Fold-change:0.9928978012582896; Z-score:-0.410981435 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 2F92 Benign neoplasm of kidney (renal oncocytoma) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Kidney | ||||
The Specified Disease | Kidney oncocytoma [ICD-11:2F92] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.7002299914235823; Fold-change:0.997166794119586; Z-score:-0.280970361 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 04 Disease of the immune system | |||||
[+] ICD-11: 4A41.0 Dermatomyositis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Dermatomyositis [ICD-11:4A41.00] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0594987152928078; Fold-change:0.9362363690219626; Z-score:-1.115130438 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 4A41.0 Dermatomyositis (juvenile form) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle organ | ||||
The Specified Disease | Juvenile dermatomyositis [ICD-11:4A41.01] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.000529124221752; Fold-change:1.0862280248952634; Z-score:1.991278548624429 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 4B20 Sarcoidosis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Lung | ||||
The Specified Disease | Sarcoidosis [ICD-11:4B20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0627346038113643; Fold-change:0.9688091875909852; Z-score:-1.677935312 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 05 Endocrine, nutritional or metabolic disease | |||||
[+] ICD-11: 5A11 Type 2 diabetes mellitus | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Type 2 diabetes [ICD-11:5A11] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.8352971472776326; Fold-change:1.015001806582108; Z-score:0.0969290934349716 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Islet of langerhans | ||||
The Specified Disease | Type ii diabetes mellitus [ICD-11:5A11] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.9788171269798338; Fold-change:0.8477135461604832; Z-score:-0.015577802 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 5A11.2 Type 2 diabetes mellitus with diabetic nephropathy | Click to Show/Hide the Full List | ||||
The Studied Tissue | Kidney | ||||
The Specified Disease | Diabetic nephropathy [ICD-11:5A11.1] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0123110805556007; Fold-change:1.1361894270949071; Z-score:10.824786458821054 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 5A14 Diabetes mellitus, type unspecified | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Diabetes mellitus [ICD-11:5A14] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0549459941810154; Fold-change:1.0283620353677192; Z-score:1.7006990780962454 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 5B81 Obesity | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Obesity [ICD-11:5B81] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.3296935626827014; Fold-change:0.9982997632618144; Z-score:0.4325320661842824 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 5B81 Obesity (morbid obesity) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Morbidly obese [ICD-11:5B81] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0981479297746966; Fold-change:1.0042411558772926; Z-score:0.9233807380038288 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 5C50.E0 Classical organic aciduria (Methylmalonic acidemia) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Kidney | ||||
The Specified Disease | Methylmalonic acidemia [ICD-11:5C50.E0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.2770975941382337; Fold-change:0.967678561844696; Z-score:-0.91811951 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 5C56.0Y Gaucher disease (non-neuronopathic Type 1) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skin | ||||
The Specified Disease | Gaucher disease type 1 [ICD-11:5C56.0Y] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.7747991393959018; Fold-change:1.0002967207321656; Z-score:-0.737936798 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 5C56.0Y Gaucher disease (subacute neuronopathic Type 3) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skin | ||||
The Specified Disease | Gaucher disease type 3 [ICD-11:5C56.0Y] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0877002698756135; Fold-change:0.9544262093029048; Z-score:-3.257474522 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 5C57.1 X-linked adrenoleukodystrophy | Click to Show/Hide the Full List | ||||
The Studied Tissue | Dermis | ||||
The Specified Disease | X linked cerebral adrenoleukodystrophy [ICD-11:5C57.1] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.7304729235023788; Fold-change:0.965555538590706; Z-score:-0.218207059 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 06 Mental, behavioural or neurodevelopmental disorder | |||||
[+] ICD-11: 6A02 Autism spectrum disorder | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brain | ||||
The Specified Disease | Autism [ICD-11:6A02] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0012161793209017; Fold-change:0.5771938057250118; Z-score:-2.221918972 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 6A20 Schizophrenia | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brodmann (1909) area 9 | ||||
The Specified Disease | Schizophrenia [ICD-11:6A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.5610651806516451; Fold-change:0.9216981132075472; Z-score:-0.314612883 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Brodmann (1909) area 11 | ||||
The Specified Disease | Schizophrenia [ICD-11:6A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.6599945175869517; Fold-change:1.002178649237473; Z-score:-0.139924992 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Brodmann (1909) area 24 | ||||
The Specified Disease | Schizophrenia [ICD-11:6A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0248778869346065; Fold-change:0.8242074927953891; Z-score:-1.137970954 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 6A60 Bipolar type I disorder (Bipolar disorder) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brodmann (1909) area 9 | ||||
The Specified Disease | Bipolar disorder [ICD-11:6A60] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.2608159054189629; Fold-change:0.7660377358490567; Z-score:-1.167157616 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Brodmann (1909) area 11 | ||||
The Specified Disease | Bipolar disorder [ICD-11:6A60] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.5196576922264208; Fold-change:1.0588235294117647; Z-score:-0.243142687 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Brodmann (1909) area 24 | ||||
The Specified Disease | Bipolar disorder [ICD-11:6A60] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0943771838851089; Fold-change:0.6839577329490875; Z-score:-1.579636039 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Dorsolateral prefrontal cortex | ||||
The Specified Disease | Bipolar disorder [ICD-11:6A60] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.8977499917845329; Fold-change:0.988013698630137; Z-score:-0.032883034 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Orbitofrontal cortex | ||||
The Specified Disease | Bipolar disorder [ICD-11:6A60] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.49984037874368; Fold-change:0.9769094010877474; Z-score:-0.429641123 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 08 Disease of the nervous system | |||||
[+] ICD-11: 8A20 Alzheimer disease | Click to Show/Hide the Full List | ||||
The Studied Tissue | Frontal cortex | ||||
The Specified Disease | Alzheimer's disease [ICD-11:8A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.4897799598426158; Fold-change:0.996059127170255; Z-score:-0.263095433 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Hippocampus | ||||
The Specified Disease | Alzheimer's disease [ICD-11:8A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0154227938604412; Fold-change:0.9576630630657574; Z-score:-1.65384054 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Middle temporal gyrus | ||||
The Specified Disease | Alzheimer's disease [ICD-11:8A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.491015228897032; Fold-change:0.997079341164521; Z-score:0.4049450622283482 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Postcentral gyrus | ||||
The Specified Disease | Alzheimer's disease [ICD-11:8A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.6558997291592403; Fold-change:0.9972225994019108; Z-score:-0.116323983 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Posterior cingulate cortex | ||||
The Specified Disease | Alzheimer's disease [ICD-11:8A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0005873590674951; Fold-change:1.1243495608405938; Z-score:1.7337495268436085 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Primary visual cortex | ||||
The Specified Disease | Alzheimer's disease [ICD-11:8A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.4392488858037719; Fold-change:1.031583191035512; Z-score:0.2530367949805504 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Superior frontal gyrus | ||||
The Specified Disease | Alzheimer's disease [ICD-11:8A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.650702703069459; Fold-change:0.9960944816458202; Z-score:-0.125988787 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Temporal cortex | ||||
The Specified Disease | Alzheimer's disease [ICD-11:8A20] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.7902807356615363; Fold-change:1.00649502327275; Z-score:-0.094358768 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 8B44.0 Hereditary spastic paraplegia | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Hereditary spastic paraplegia [ICD-11:8B44.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.8070266370396748; Fold-change:0.9939837178051274; Z-score:-0.134911558 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 8B60.0 Amyotrophic lateral sclerosis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Amyotrophic lateral sclerosis [ICD-11:8B60.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.1900056275433537; Fold-change:0.98241720130424; Z-score:-0.544757715 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 8C70.1 Duchenne muscular dystrophy | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Duchenne muscular dystrophy [ICD-11:8C70.1] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.4784085500566053; Fold-change:1.007442965558617; Z-score:0.2628487442217327 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 8C70.1 Duchenne/Becker muscular dystrophy | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Becker muscular dystrophy [ICD-11:8C70.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.5285183275956078; Fold-change:0.9959907638266722; Z-score:-0.298528818 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 8C70.2 Emery-Dreifuss muscular dystrophy | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Autosomal dominant emery dreifuss muscular dystrophy [ICD-11:8C70.2] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0849163962332448; Fold-change:1.018283270379388; Z-score:0.985843126525732 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | X linked recessive emery dreifuss muscular dystrophy [ICD-11:8C70.2] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.1828565290964511; Fold-change:1.0215381833520794; Z-score:0.7262202595950911 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 8C70.3 Facioscapulohumeral muscular dystrophy | Click to Show/Hide the Full List | ||||
The Studied Tissue | Muscle | ||||
The Specified Disease | Facioscapulohumeral dystrophy [ICD-11:8C70.3] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.2393843735821413; Fold-change:1.173913043478261; Z-score:0.908157175459012 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Myoblast | ||||
The Specified Disease | Facioscapulohumeral dystrophy [ICD-11:8C70.3] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.6497440901611418; Fold-change:0.7229299363057324; Z-score:1.2044666104139905 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Myotube | ||||
The Specified Disease | Facioscapulohumeral dystrophy [ICD-11:8C70.3] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.6262183814938995; Fold-change:0.6033057851239669; Z-score:7.2875 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Fascioscapulohumeral muscular dystrophy [ICD-11:8C70.3] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0646272832008197; Fold-change:0.9778791591105376; Z-score:-0.712779422 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
[+] ICD-11: 8C70.4 Limb-girdle muscular dystrophy | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Limb girdle muscular dystrophy 2a [ICD-11:8C70.4] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.9552602369993808; Fold-change:1.0119351319401335; Z-score:0.0224898640042391 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Limb girdle muscular dystrophy 2b [ICD-11:8C70.4] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.1290113218241254; Fold-change:0.9843299931987928; Z-score:-0.571994921 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Limb girdle muscular dystrophy 2i [ICD-11:8C70.4] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.1492755880655268; Fold-change:0.9807560843385388; Z-score:-0.660003161 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 8C71.0 Myotonic dystrophy | Click to Show/Hide the Full List | ||||
The Studied Tissue | Heart left ventricle | ||||
The Specified Disease | Myotonic dystrophy [ICD-11:8C71.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.7476991991668949; Fold-change:1.072463768115942; Z-score:-0.924500327 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: 8C81 Critical illness myopathy (acute quadriplegic myopathy) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle | ||||
The Specified Disease | Acute quadriplegic myopathy [ICD-11:8C81] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.2896733988552433; Fold-change:0.9911406618539434; Z-score:-0.509259168 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 11 Disease of the circulatory system | |||||
[+] ICD-11: BA8Z Diseases of coronary artery, unspecified (coronary artery disease) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Epicardial fat | ||||
The Specified Disease | Coronary artery disease [ICD-11:BA8Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.3092474842397691; Fold-change:0.9928842275527532; Z-score:-0.372274821 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Subcutaneous adipose tissue | ||||
The Specified Disease | Coronary artery disease [ICD-11:BA8Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0982156563325641; Fold-change:0.9740883136698224; Z-score:-0.792624494 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: BD10 Congestive heart failure | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skeletal muscle tissue | ||||
The Specified Disease | Heart failure [ICD-11:BD10] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.7688661957886824; Fold-change:1.25; Z-score:0.288675134594813 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: BD10 Congestive heart failure (post-ischemic) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Left ventricle | ||||
The Specified Disease | Post ischemic heart failure [ICD-11:BD10] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.5380454157213937; Fold-change:0.9919013354205432; Z-score:-0.747889052 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 13 Disease of the digestive system | |||||
[+] ICD-11: DB91 Acute or subacute hepatic failure | Click to Show/Hide the Full List | ||||
The Studied Tissue | Liver | ||||
The Specified Disease | Acute liver failure [ICD-11:DB91.Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.6017459978020105; Fold-change:0.9627141601648996; Z-score:-0.194535101 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: DB92.1 Non-alcoholic steatohepatitis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Liver | ||||
The Specified Disease | Non alcoholic steatohepatitis [ICD-11:DB92.1] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.2069179949953808; Fold-change:1.037021810510067; Z-score:0.5238164727535016 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: DD70 Crohn disease | Click to Show/Hide the Full List | ||||
The Studied Tissue | Ileum | ||||
The Specified Disease | Crohn's disease [ICD-11:DD70.Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.5930298546828545; Fold-change:1.0095238095238095; Z-score:0.1265255070129766 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Colonic mucosa | ||||
The Specified Disease | Crohn's disease [ICD-11:DD70.Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.3650716116740654; Fold-change:1.0046595909203455; Z-score:-0.36894484 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Ileal mucosa | ||||
The Specified Disease | Crohn's disease [ICD-11:DD70.Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0120123257818651; Fold-change:0.9886356314531676; Z-score:-0.815451127 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: DD71 Ulcerative colitis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Caecum | ||||
The Specified Disease | Active ulcerative colitis [ICD-11:DD71.Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.7625419971466655; Fold-change:1.023972893094842; Z-score:0.1802864440649015 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Left colon | ||||
The Specified Disease | Active ulcerative colitis [ICD-11:DD71.Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0369597389789483; Fold-change:0.9613409658603552; Z-score:-2.278923746 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Rectum | ||||
The Specified Disease | Active ulcerative colitis [ICD-11:DD71.Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.1638671157663478; Fold-change:0.9650028059424458; Z-score:-1.493789466 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Transverse colon | ||||
The Specified Disease | Active ulcerative colitis [ICD-11:DD71.Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.4146865589051938; Fold-change:0.965736540938446; Z-score:-1.366786999 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: DD7Z Inflammatory bowel disease, unspecified | Click to Show/Hide the Full List | ||||
The Studied Tissue | Colon | ||||
The Specified Disease | Inflammatory bowel disease [ICD-11:DD7Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.1593858922674264; Fold-change:1.0027641931950595; Z-score:-0.516732262 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Sigmoid colon | ||||
The Specified Disease | Inflammatory bowel disease [ICD-11:DD7Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.9382786298606112; Fold-change:0.9978313094170876; Z-score:0.0149140247239219 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 14 Disease of the skin | |||||
[+] ICD-11: EA80 Atopic dermatitis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skin | ||||
The Specified Disease | Atopic eczema [ICD-11:EA80] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.4396540941392611; Fold-change:1.0025145186535611; Z-score:0.245616518372759 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: EA91 Lichen planus (oral mucosal involvement) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Mouth mucosa | ||||
The Specified Disease | Oral lichen planus [ICD-11:EA91.42] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.7717830784346007; Fold-change:0.9957096809125032; Z-score:-0.126965476 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: ED90.0 Rosacea | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skin | ||||
The Specified Disease | Rosacea [ICD-11:ED90.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.8840825830121211; Fold-change:0.9953000693976278; Z-score:-0.036863618 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: EK90.0 Actinic keratosis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skin | ||||
The Specified Disease | Actinic keratosis [ICD-11:EK90.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.3899997395390013; Fold-change:1.2727272727272727; Z-score:2.3759413314477755 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 15 Disease of the musculoskeletal system/connective tissue | |||||
[+] ICD-11: FA0Z Osteoarthritis, unspecified site | Click to Show/Hide the Full List | ||||
The Studied Tissue | Bone | ||||
The Specified Disease | Osteoarthritis [ICD-11:FA0Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0436673671302305; Fold-change:1.0739751205672927; Z-score:0.6634184187068654 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 16 Disease of the genitourinary system | |||||
[+] ICD-11: GB61 Chronic kidney disease | Click to Show/Hide the Full List | ||||
The Studied Tissue | Kidney | ||||
The Specified Disease | Chronic kidney disease [ICD-11:GB61.Z] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0067115397539761; Fold-change:0.9042901072885188; Z-score:-1.165810141 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 20 Developmental anomaly | |||||
[+] ICD-11: LA88.2 Tetralogy of Fallot | Click to Show/Hide the Full List | ||||
The Studied Tissue | Heart ventricle | ||||
The Specified Disease | Tetralogy of fallot [ICD-11:LA88.2] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.2728984221051799; Fold-change:1.1785714285714286; Z-score:-0.297446318 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: LB20.21 Biliary atresia | Click to Show/Hide the Full List | ||||
The Studied Tissue | Liver | ||||
The Specified Disease | Biliary atresia [ICD-11:LB20.21] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:8.63667809429003e-06; Fold-change:0.9545228559344132; Z-score:-1.557012454 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: LB70.00 Unicoronal craniosynostosis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skull | ||||
The Specified Disease | Coronal craniosynostosis [ICD-11:LB70.00] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.9250409232153426; Fold-change:1.1039755351681957; Z-score:0.1107487867263418 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: LB70.02 Lambdoid craniosynostosis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skull | ||||
The Specified Disease | Lambdoid craniosynostosis [ICD-11:LB70.3] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.3717893548729747; Fold-change:1.3761467889908257; Z-score:1.2018294263265987 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: LB70.03 Metopic craniosynostosis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skull | ||||
The Specified Disease | Metopic craniosynostosis [ICD-11:LB70.2] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.4294905389586629; Fold-change:1.143730886850153; Z-score:0.9967390805370766 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: LB70.0Y Sagittal craniosynostosis | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skull | ||||
The Specified Disease | Sagittal craniosynostosis [ICD-11:LB70.1] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.7731576741855661; Fold-change:0.8807339449541285; Z-score:-0.287946845 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: LC02 Sebaceous naevus (nevus sebaceus of Jadassohn) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Skin | ||||
The Specified Disease | Sebaceous of jadassohn nevus [ICD-11:LD2D.Y] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0124966706253975; Fold-change:3; Z-score:6.127258315155433 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: LD40.0 Complete trisomy 21 (Down syndrome) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brain | ||||
The Specified Disease | Down syndrome [ICD-11:LD40.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0072822437262036; Fold-change:0.9396993533594692; Z-score:-2.019126105 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 25 Codes for special purposes | |||||
[+] ICD-11: RA01 COVID-19 | Click to Show/Hide the Full List | ||||
The Studied Tissue | Lung | ||||
The Specified Disease | Covid [ICD-11:RA01.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.205045573077792; Fold-change:0.8108108108108109; Z-score:-0.469186567 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
The Studied Tissue | Colon | ||||
The Specified Disease | Covid [ICD-11:RA01.0] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.034006770827891; Fold-change:0.4757709251101321; Z-score:-1.086807213 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
ICD-11: 28 Extension Codes | |||||
[+] ICD-11: XH12D2 Pilocytic astrocytoma | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brain | ||||
The Specified Disease | Astrocytoma, pilocytic [ICD-11:XH12D2] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0009583501619308; Fold-change:0.8695853482808482; Z-score:-1.484889133 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: XH1L48 Subependymal giant cell astrocytoma | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brain | ||||
The Specified Disease | Subependymal giant cell astrocytoma [ICD-11:XH1L48] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.0620368946883536; Fold-change:0.6588276575640267; Z-score:-3.119538855 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: XH77N6 Clear cell sarcoma, NOS (soft tissue) | Click to Show/Hide the Full List | ||||
The Studied Tissue | Kidney | ||||
The Specified Disease | Clear cell sarcoma [ICD-11:XH77N6] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:0.2293867888231565; Fold-change:0.9772388681716536; Z-score:-0.996096756 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
[+] ICD-11: XH7ZQ4 Atypical teratoid/rhabdoid tumour | Click to Show/Hide the Full List | ||||
The Studied Tissue | Brain | ||||
The Specified Disease | Atypical teratoid rhabdoid tumor [ICD-11:XH7ZQ4] | ||||
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value:5.3816932494060577e-08; Fold-change:0.6833569146804969; Z-score:-6.144695945 | ||||
DT expression in the diseased tissue of patients
DT expression in the normal tissue of healthy individuals
|
|||||
![]() |
![]() |
||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.